Pharmaceutical manufacturers of Spironolactone

Piramal Group has interests in a portfolio of businesses including financial services (Piramal Enterprises Limited), pharmaceuticals (Piramal Pharma Limited), and real estate (Piramal Realty). With operations in 30 countries and brand presence in over 100 markets, the Group’s turnover is ~$1.9 billion in FY 2022. Driven by its core values, the Group pursues inclusive growth, while adhering to ethical and value-driven practices. Piramal Foundation has initiatives in primary healthcare, nutrition, water, and social sector ecosystems.

Euroapi focuses on revolutionizing active component solutions to sustainably fulfill the demands of clients and patients globally. As a prominent figure in active pharmaceutical ingredients, we possess a comprehensive portfolio of around 200 products, encompassing a wide range of technologies, and are constantly developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO). Our 3,350 employees are driven by the commitment to improving access to essential therapies and promoting health

Dipharma is a global Contract Development and Manufacturing Organisation (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients, with more than 500 employees, 4 cGMP plants and commercial offices in Italy, U.S.A. and China. We put our heart and soul into supporting our customers with a competitive and highly proactive approach, backed by 75 years of experience in safely handling hazardous chemical processes using state-of-the-art technologies. As a third-generation family-owned company, we have a long history of stability, commitment and financial solidity. We know how to deliver on creative innovation and we understand the critical importance of matching timelines, while operating in full respect of international regulations, Intellectual Property and third-party patents.

Founded as Xianju Pharmacy Plant in 1972, Xianju Pharmaceutical Co., Ltd. (stock code: 002332) practices the corporate philosophy of “ your health and happiness, my sincerity and service” and focuses on steroid hormones with the vision of “ Becoming the one of the Top 10 steroid hormone suppliers in the world and a business well-received among customers and employees.” It has a total capital stock of 989.204866 million yuan and more than 3600 employees. As a key high-tech enterprise of the National Torch Plan, the company ranked 67th among the top 100 in the Chinese pharmaceutical industry in 2020 with a provincial steroid medicine engineering technology research center in Zhejiang Province and a national post-doctoral center. As the only company holding fast to the business pattern integrating bulk pharmaceutical chemicals and preparations, the company specializes in the research, production and sale of bulk pharmaceutical chemicals and steroid preparations. In its product development, the company sticks to the four major fields of health care (gynecology, anesthesiology, respiratory medicine, and dermatology) to build mixes of products and services. The company has established long-term partnership with more than 20 domestic prestigious research institutes and universities including the Shanghai institute of Organic Chemistry, Chinese Academy of Sciences, Zhejiang University and China Pharmaceutical University to bring in senior researchers and gradually align with the new drug development in the world. The company has formed a technical framework that originates from overseas high-end research institutions, assimilates through the research institutions in Hangzhou and Xianju and Implements them with the base in Xianju. Under the company, there are 20 wholly-owned and holding subsidiaries such as time Xianju Pharmaceutical Co., Ltd. The company has three core manufacturing platforms, which are Xianju Yangfu bulk pharmaceutical chemicals production zone, Xianju Yangfu preparation production zone and Linhai Yangfu productions zone at home and two standard bulk pharmaceutical chemicals plants under the name of NewChem, its subsidiary in Italy. Xianju Pharma advocates the culture celebrating authenticity, win-win results and innovation and core values of honesty, hard work, openness, studiousness, responsibility and mutual benefit. Upholding the strategic objective of achieving win-win results with customers, enterprises, employees and communities, the company promotes the values that individuals’ value is reflected when they benefit their communities and companies. In its future development, the company will continue optimizing its business management, developing high-tech products and leverage on its large business size to achieve high-quality development and make contributions to the health care of mankind.

We, at TIEFENBACHER GROUP, are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. We believe that the access to affordable high quality-healthcare is a human right. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is the driving force of making high-quality pharmaceuticals more affordable, more available, and better than before. 100% family owned since 1963, we are a purpose-driven healthcare company providing best-in-class solutions throughout the entire pharmaceutical value chain. From initial idea to market access: We distribute raw materials and develop, manufacture, and register finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create novel healthcare solutions. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-functional structures, we tap into our full potential and stay at the forefront of our field.

Roche CustomBiotech offers an extensive array of products and services for the diagnostics, biotechnology, and pharmaceutical industries. Our range of offerings includes enzymes, coenzymes, substrates, PCR-based kits for rapid microbiological methods, as well as the Cedex HiRes and Cedex Bio HT Analyzers for monitoring cell growth and fermentation processes.

TIANJIN PHARMACEUTICAL HOLDINGS CO., LTD. advocates the corporate core values of "Love, Integrity and Power", and has been working to improve people's health and well-being, protect people's lives, benefit the public and safeguard people's happy life, and is committed to building a market-driven, technology-empowered leader in the health industry.

Nortec Química is the largest manufacturer of Active Pharmaceutical Ingredients (APIs) in Latin America and began its activities determined to guarantee quality medicines with APIs developed in Brazil. To this end, the company combined the knowledge of the main National Research Centers with the experience of the Brazilian Chemical and Petrochemical Industry. Nortec Química is very important in the Brazilian pharmaceutical scenario and in the Unified Health System (SUS), producing APIs for branded, generic and similar drugs and drugs for neglected diseases.

Dasami Lab Private Limited was officially established through MCA on the 24th of July 2015. Categorized as a private limited company, it falls under the classification of Non Government Company. The company is registered at Registrar of Companies(ROC) in Hyderabad, with an Authorized Share Capital of Rs. 110 CR and a paid up capital of 110 CR.

The Medimpex brand has been well-established for more than 60 years with a strong heritage in the pharmaceutical sector in Hungary and its international commerce. Medimpex UK has acted as the link between Hungarian pharmaceuticals and the United Kingdom as well as the Republic of Ireland, offering a dependable and well-established supply chain. As a wholly owned subsidiary of Gedeon Richter, Hungary's largest pharmaceutical manufacturer, Medimpex takes pride in upholding the finest traditions in promoting Hungarian pharmaceutical products. We are committed to marketing various products on behalf of EGIS PLC and other Hungarian suppliers in the UK.

Tianjin Jinjin Pharmaceutical Limited Company, since its establishment in 1993, has been devoting into the research and production of the steroid drugs. JINJIN merged with SPH SINE in September 2017. The main product includes APIs Spironolactone, Hydrocortisone, Hydrocortisone Acetate and Partial tablets product. The tablets are currently only available for the Chinese market.